Litcius/Paper detail

Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light Chain

Ahmed Abdelhak, Jens Kühle, Ari Green

2023JAMA Neurology23 citationsDOI

Abstract

This Viewpoint describes the benefits and limitations of using neurofilament light chain (NfL) as a marker of real-time disease activity and treatment response in multiple sclerosis.

Topics & Concepts

BiomarkerMedicineComputational biologyNeurosciencePsychologyBiologyBiochemistryAmyotrophic Lateral Sclerosis ResearchMultiple Sclerosis Research StudiesSkin and Cellular Biology Research
Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light Chain | Litcius